Treatment of addiction to ethanol and addictive-related behavior
Patent
·
OSTI ID:874137
- Manorville, NY
- Cos Cob, CT
The present invention provides a highly efficient method for treating alcohol addiction and for changing addiction-related behavior of a mammal suffering from alcohol addiction. The method includes administering to a mammal an effective amount of gamma vinylGABA or a pharmaceutically acceptable salt thereof. In one embodiment, the method of the present invention includes administering to the mammal an effective amount of a composition which increase central nervous system GABA levels wherein the effective amount is sufficient to diminish, inhibit or eliminate behavior associated with craving or use of alcohol.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
- DOE Contract Number:
- AC02-98CH10886
- Assignee:
- Brookhaven Science Associates (Upton, NY)
- Patent Number(s):
- US 6323239
- OSTI ID:
- 874137
- Country of Publication:
- United States
- Language:
- English
Similar Records
Treatment of addiction and addiction-related behavior
Treatment of addiction and addiction-related behavior
Treatment of PCP addiction and PCP addiction-related behavior
Patent
·
Wed Jan 01 00:00:00 EST 2003
·
OSTI ID:874137
Treatment of addiction and addiction-related behavior
Patent
·
Tue Jul 15 00:00:00 EDT 2003
·
OSTI ID:874137
Treatment of PCP addiction and PCP addiction-related behavior
Patent
·
Tue Jan 01 00:00:00 EST 2002
·
OSTI ID:874137
Related Subjects
treatment
addiction
ethanol
addictive-related
behavior
provides
highly
efficient
method
treating
alcohol
changing
addiction-related
mammal
suffering
administering
effective
amount
gamma
vinylgaba
pharmaceutically
acceptable
salt
embodiment
composition
increase
central
nervous
gaba
levels
sufficient
diminish
inhibit
eliminate
associated
craving
pharmaceutically acceptable
efficient method
/514/
addiction
ethanol
addictive-related
behavior
provides
highly
efficient
method
treating
alcohol
changing
addiction-related
mammal
suffering
administering
effective
amount
gamma
vinylgaba
pharmaceutically
acceptable
salt
embodiment
composition
increase
central
nervous
gaba
levels
sufficient
diminish
inhibit
eliminate
associated
craving
pharmaceutically acceptable
efficient method
/514/